A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A southwest oncology group trial
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (3) , 354-358
- https://doi.org/10.1016/0090-8258(90)90366-s
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cancer Statistics, 1989CA: A Cancer Journal for Clinicians, 1989
- Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.Journal of Clinical Oncology, 1988
- Failure of Allopurinol to Provide Clinically Significant Protection against the Hematologic Toxicity of a Bolus 5-FU ScheduleOncology, 1986
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- A phase II study of cis‐diamminedichloroplatinum and 5‐fluorouracil in advanced upper aerodigestive neoplasmsHead & Neck Surgery, 1984
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- HIGH-DOSE ALLOPURINOL MODULATION OF 5-FU TOXICITY - PHASE-I TRIAL OF AN OUTPATIENT DOSE SCHEDULE1982
- Modulation of 5-fluorouracil toxicity by allopurinol in manCancer, 1981
- Allopurinol modulation of fluorouracil toxicityCancer Chemotherapy and Pharmacology, 1981